List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 27 studies with search of: Propylene Glycol
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Active, not recruiting A Pharmacokinetic Study of Melphalan HCL for Injection (Propylene Glycol-Free) and Alkeran for Injection for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Condition: Multiple Myeloma
Interventions: Drug: Melphalan HCL for Injection (Propylene Glycol-Free)/Alkeran for Injection;   Drug: Alkeran for Injection/Melphalan HCL for Injection (Propylene Glycol-Free)
2 Completed An Open-Label, Single-Center Study Evaluating the Effect of Systane Balance on Video Ocular Protection Index (OPI) and Blink Patterns in Patients Diagnosed With Dry Eye
Condition: Dry Eye Syndrome
Intervention: Other: SYSTANE® Balance Lubricant Eye Drops
3 Completed Tear Film Break-up Time After Instillation of Artificial Tears
Condition: Keratoconjunctivitis Sicca
Interventions: Drug: glycerin;   Drug: polyethylene glycol 400/propylene glycol
4 Completed Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
Condition: Dry Eye
Interventions: Other: Systane Balance Lubricating Eye Drops;   Other: OPTIVE™
5 Unknown † Comparison Between Three Freezing Protocols to Preserve Human Embryos
Condition: In Vitro Fertilization
Interventions: Procedure: Slow freezing method with propane diol;   Procedure: Vitrification solution - Irvine;   Procedure: Vitrification solution - vitrolife
6 Active, not recruiting The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction
Condition: Meibomian Gland Dysfunction
Interventions: Drug: Systane Balance;   Drug: Optive Lubricant Eye Drops
7 Completed Cross-Over Evaluation of Two Lubricating Eye Drops
Condition: Dry Eye
Interventions: Drug: Polyethylene Glycol 400 0.4%;   Drug: Propylene Glycol 0.3%;   Drug: 0.15% sodium Hyaluronate;   Drug: sodium chloride;   Drug: sodium phosphate monobasic
8 Completed Mechanisms of Skin Repair by Topical Estrogen
Condition: Skin Wrinkling
Intervention: Drug: Topical 17-beta estradiol in ethanol/propylene glycol (ETOH/PG)
9 Completed Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining
Condition: Corneal Staining
Intervention: Drug: sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95
10 Unknown † Efficacy of the Combination Bismuth + Neomycin + Procaine in the Treatment of Recurrent Aphthous Ulceration
Condition: Aphtous Ulcers
Interventions: Drug: Bismu-Jet;   Other: Placebo
11 Completed Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye Subjects
Condition: Dry Eye
Intervention: Other: Systane Ultra Lubricant Eye Drops
12 Completed A Study to Determine the Maintenance of Effect After Long-Term Treatment of Sativex® in Subjects With Neuropathic Pain
Conditions: Pain;   Peripheral Neuropathy
Interventions: Drug: Sativex®;   Drug: Placebo
13 Completed A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy
Conditions: Pain;   Diabetic Neuropathy
Interventions: Drug: Sativex;   Drug: Placebo
14 Completed A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
15 Completed A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia
Conditions: Pain;   Peripheral Neuropathy
Interventions: Drug: Sativex;   Drug: Placebo
16 Completed A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.
Conditions: Pain;   Peripheral Neuropathy
Interventions: Drug: Sativex®;   Drug: Placebo
17 Completed
Has Results 		A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
18 Not yet recruiting Study of a Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
Condition: Neuroblastoma Recurrent
Interventions: Drug: Dasatinib;   Drug: Rapamycin;   Drug: Irinotecan;   Drug: Temozolomide
19 Completed Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.
Conditions: Dry Eye Symptoms;   Visual Performance
Intervention: Other: Systane® Ultra
20 Completed Study on Regenerative Treatment of Intra-bony Defects
Conditions: Periodontal Disease;   Periodontal Attachment Loss
Interventions: Device: Ostim;   Device: Emdogain

Previous Page Studies Shown (1-20) Next Page (21-27)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services